ISIS-4 - REPLY

ISIS-4 - REPLY

Bibliographic Details
Main Authors:	Collins, R, Peto, R, Sleight, P
Format:	Journal article
Published:	1995

Similar Items

AFTER ISIS-3 - REPLY
by: Collins, R, et al.
Published: (1992)

ISIS-3 - REPLY
by: Collins, R, et al.
Published: (1991)

ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION
by: Collins, R, et al.
Published: (1989)

MORNING PEAK IN THE INCIDENCE OF MYOCARDIAL-INFARCTION - EXPERIENCE IN THE ISIS-2 TRIAL
by: Willich, S, et al.
Published: (1992)

Heart Protection Study - Reply
by: Collins, R, et al.
Published: (2003)

ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
by: Collins, R, et al.
Published: (1993)

MRC/BHF Heart Protection Study - Reply
by: Collins, R, et al.
Published: (2002)

New analyses of Heart Protection Study - Reply
by: Collins, R, et al.
Published: (2004)

ISIS COLLABORATIVE GROUP - RANDOMIZED TRIAL OF EARLY IV ATENOLOL IN MYOCARDIAL-INFARCTION - SUBSIDIARY ANALYSES
by: Sleight, P, et al.
Published: (1986)

Comments on the MRC/BHF Heart Protection Study - Authors' reply
by: Collins, R, et al.
Published: (2003)

ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
by: Baigent, C, et al.
Published: (1998)

The authors reply
by: Collins, R, et al.
Published: (2009)

TRIALS OF ANTIPLATELET THERAPY - REPLY
by: Baigent, C, et al.
Published: (1994)

Radiotherapy and surgery in early breast cancer - Reply
by: Peto, R, et al.
Published: (1996)

Analyses of Cancer Data from Three Ezetimibe Trials Reply
by: Collins, R, et al.
Published: (2009)

LOW CHOLESTEROL AND CORONARY HEART-DISEASE - REPLY
by: Chen, Z, et al.
Published: (1991)

Significant reduction in mortality with streptokinase given 7-24 hours after pain onset.
by: Collins, R, et al.
Published: (1988)

Wider inclusion criteria needed for thrombolytic therapy.
by: Peto, R, et al.
Published: (1989)

OVERVIEW OF MORTALITY RESULTS FROM ALL RANDOMIZED CONTROLLED TRIALS OF EARLY IV BETA-BLOCKADE AFTER MYOCARDIAL-INFARCTION
by: Sleight, P, et al.
Published: (1986)

In search of genetic precision - Reply
by: Keaveny, B, et al.
Published: (2003)

ISIS-3 SHOWS SIMILAR RESULTS WITH DIFFERENT THROMBOLYTIC AGENTS
by: Peto, R
Published: (1991)

ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.
by: Collins, R, et al.
Published: (1995)

Authors' reply [5]
by: Chen, Z, et al.
Published: (2006)

The authors reply
by: Jha, P, et al.
Published: (2008)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
by: Collins, R, et al.
Published: (1997)

COMMIT/CCS-2 studies - Authors' reply
by: Chen, Z, et al.
Published: (2006)

ASPIRIN AND THE STOMACH - REPLY
by: Doll, R, et al.
Published: (1981)

Interpretation of IST and CAST stroke trials - Reply
by: Chen, Z, et al.
Published: (1997)

Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
by: Collins, R, et al.
Published: (1997)

Clopidogrel and metoprolol in myocardial infarction - Reply
by: Chen, Z, et al.
Published: (2006)

MORBIDITY VERSUS MORTALITY - REPLY
by: Doll, R, et al.
Published: (1982)

Authors' reply
by: Peto, R, et al.
Published: (2013)

Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)

Aspirin in the primary prevention of vascular disease Reply
by: Baigent, C, et al.
Published: (2009)

Helicobacter pylori and surgery - Reply
by: Danesh, J, et al.
Published: (1998)

Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.
by: Alexopoulos, D, et al.
Published: (1991)

Beta blockade during and after myocardial infarction: an overview of the randomized trials.
by: Yusuf, S, et al.
Published: (1985)

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
by: Collins, R, et al.
Published: (2004)

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY
by: Peto, R
Published: (1985)

In reply
by: Armitage, J, et al.
Published: (2010)